Pictet Asset Management’s Guardant Health GH Stock Holding History

Pictet Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.4M	Sell	131,141 -35,243	-21%	-$3.54M	0.01%	622
2025 Q4	$16.9M	Sell	166,384 -89,386	-35%	-$8M	0.02%	561
2025 Q3	$15.9M	Sell	255,770 -62,648	-20%	-$3.41M	0.02%	574
2025 Q2	$16.2M	Sell	318,418 -38,252	-11%	-$1.71M	0.02%	559
2025 Q1	$15.4M	Sell	356,670 -236,846	-40%	-$10.2M	0.02%	558
2024 Q4	$18.1M	Sell	593,516 -29,555	-5%	-$831K	0.02%	532
2024 Q3	$14.3M	Sell	623,071 -41,037	-6%	-$1.16M	0.02%	568
2024 Q2	$19.2M	Sell	664,108 -485,513	-42%	-$11.3M	0.02%	478
2024 Q1	$22.2M	Buy	1,149,621 +198,828	+21%	+$4.26M	0.02%	474
2023 Q4	$25.7M	Buy	950,793 +66,000	+7%	+$1.73M	0.03%	418
2023 Q3	$26.2M	Buy	+884,793	New	+$31.1M	0.03%	397

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management's GH Position: Q1 2026 in Review

Pictet Asset Management reduced its Guardant Health (GH) stake by 21% in Q1 2026, selling an estimated $3.54M and leaving 131,141 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #622.

Pictet Asset Management first reported a position in GH in Q3 2023 and has held it in 11 quarters since. The position peaked at $26.2M in Q3 2023. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Pictet Asset Management held 131,141 shares of Guardant Health worth $11.4M as of Q1 2026.
Pictet Asset Management sold 35,243 Guardant Health shares in Q1 2026, an estimated $3.54M.
Guardant Health made up 0.01% of Pictet Asset Management's portfolio in Q1 2026, its #622 holding.
Pictet Asset Management first reported a position in Guardant Health in Q3 2023 and has held it in 11 quarters since.
Pictet Asset Management's Guardant Health position peaked at $26.2M in Q3 2023.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.